Moreover, Oct4 involvement in radioresistance is supported by clinical findings where Oct4-positive head and neck squamous cell carcinoma patients had reduced survival post-radiotherapy compared to Oct4-negative cases [23]. This evidence concerns the gene POU5F1 and head and neck squamous cell carcinoma.